Top Projects to Watch - 2012 Presentations

The Top 10 Projects to Watch are chosen to present in each therapeutic area, and are hand-picked by a panel of independent experts who screen hundreds of compounds and weigh their potential as future products. Many presenting companies in previous years have gone on to establish major partnerships.

The criteria were:

• Large market, large unmet need, with increasing opportunity
• History of the molecule and drug
• Strong science
• Strong company
• Diversity of indications
• Potential for new opportunities beyond the initial indications
• Multi-level partnering opportunities, i.e., biotech to biotech as well as pharma to biotech

Please complete this form to access the presentations by the companies nominated to present their Top Project to Watch: